Type II Inflammation Journal Club
196
1-10 of 10
- Type II Inflammation Journal Club
Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
Lisa Swanson, MD, FAAD; Michelle B. Tarbox, MDLisa Swanson, MD, FAAD; Michelle B. Tarbox, MD - Type II Inflammation Journal Club
Fertility Medications and Chronic Spontaneous Urticaria
Neal Bhatia, MD, FAAD; Michelle B. Tarbox, MDNeal Bhatia, MD, FAAD; Michelle B. Tarbox, MD - Type II Inflammation Journal Club
A Closer Look at OX40 Pathway Modulation
Walter Liszewski, MD; Matthew Zirwas, MDWalter Liszewski, MD; Matthew Zirwas, MD - Type II Inflammation Journal Club
Analyzing the Overlap Between Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
Neal Bhatia, MD, FAAD; Jason E. Hawkes, MD, MS, FAADNeal Bhatia, MD, FAAD; Jason E. Hawkes, MD, MS, FAAD - Type II Inflammation Journal Club
Strategizing to Capitalize on Emollients
Neal Bhatia, MD; Dawn Eichenfield, M.D., Ph.D.Neal Bhatia, MD; Dawn Eichenfield, M.D., Ph.D. - Type II Inflammation Journal Club
Implications of the Overlap Between CSU and Atopic Dermatitis
Neal Bhatia, MD; Walter Liszewski, MDNeal Bhatia, MD; Walter Liszewski, MD - Type II Inflammation Journal Club
3 Years of Real-World Data for an AD Biologic
Lisa Swanson, MD, FAAD; Neal Bhatia, MD, FAADLisa Swanson, MD, FAAD; Neal Bhatia, MD, FAAD - Type II Inflammation Journal Club
The Benefits of Balneotherapy for Atopic Dermatitis
Peter A. Lio, MD; Karan Lal, DO, MS, FAADPeter A. Lio, MD; Karan Lal, DO, MS, FAAD - Type II Inflammation Journal Club
Balneotherapy Continued: A Future in US Dermatology?
Peter A. Lio, MD; Karan Lal, DO, MS, FAADPeter A. Lio, MD; Karan Lal, DO, MS, FAAD
